IRONWOOD PHARMACEUTICALS INC - Class A Common Stock, Par Value $0.001 Per Share (IRWD)

84 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock, Par Value $0.001 Per Share as of Q1 2025.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock, Par Value $0.001 Per Share (IRWD) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21.3M shares of 160M outstanding shares and own 13.32% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (11.9M shares), Pacer Advisors, Inc. (1.79M shares), FEDERATED HERMES, INC. (1.31M shares), ROYCE & ASSOCIATES LP (735K shares), LOS ANGELES CAPITAL MANAGEMENT LLC (688K shares), XTX Topco Ltd (553K shares), GSA CAPITAL PARTNERS LLP (525K shares), Bank of New York Mellon Corp (500K shares), Universal- Beteiligungs- und Servicegesellschaft mbH (418K shares), and Robeco Institutional Asset Management B.V. (381K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.